Subchondral treatment to prevent the progression of osteoarthritis of the joint
Methods for the prevention, or delayed onset or progression of, bone marrow edema or bone marrow lesion, and subchondral treatment to prevent the progression of osteoarthritis of a joint are disclosed. The methods involve treating the subchondral bone, while preserving, as much as possible, the joint's articular and cartilage surface. The methods could be performed before, during, or after an initial arthroscopic surgery to repair the joint. Associated devices and instruments for treatment of the subchondral bone are also disclosed.
1. A method for treating subchondral bone in a first bone adjacent a knee joint having a meniscus to try to prevent or delay the onset of a bone marrow edema in subchondral bone of the first bone, the first bone having articular cartilage, the subchondral bone occurring under the articular cartilage, the method comprising:
identifying a varus or valgus alignment in the knee joint;
identifying damage in the articular cartilage of the first bone;
obtaining imaging of the first bone that is usable to determine if the imaging detects a bone marrow edema in the subchondral bone, wherein the imaging obtained includes one or more types of imaging that each fail to detect a bone marrow edema in the subchondral bone, said one or more types of imaging including an MRI of the first bone;
creating, despite the one or more types of imaging failing to detect a bone marrow edema in the subchondral bone, an access path to the subchondral bone, wherein said creating is conducted without creating a void in the subchondral bone that opens into the overlying articular cartilage of the first bone so as to preserve an existing condition of the overlying articular cartilage of the first bone; and
injecting an injectable fluid material into the subchondral bone via the access path for treating the subchondral bone, wherein the injectable fluid material includes an osteogenic, osteoconductive and/or osteoinductive material, wherein the injectable fluid material is left in the subchondral bone without also delivering and leaving a solid structural implant in the subchondral bone in addition to the injectable fluid material.
2. The method of claim 1 , wherein the MRI is a T2-weighted MRI.
3. The method of claim 1 , wherein the injectable fluid material includes bone marrow.
4. The method of claim 1 further comprising identifying tears in the meniscus.
5. The method of claim 1 , wherein the damage in the articular cartilage includes articular cartilage edema.
6. The method of claim 1 , wherein the damage in the articular cartilage includes tears in the articular cartilage.
7. The method of claim 1 , wherein the damage in the articular cartilage includes a crevice extending more than 50% of the thickness of the articular cartilage.
8. The method of claim 1 , wherein the damage in the articular cartilage exposes subchondral bone.
9. The method of claim 1 , wherein said identifying damage in the articular cartilage includes visualizing the damage arthroscopically.
10. The method of claim 1 further comprising arthroscopically visualizing the first bone.
11. The method of claim 1 further comprising arthroscopically repairing a portion of the articular cartilage.
12. The method of claim 1 further comprising arthroscopically repairing a meniscal tear.
13. The method of claim 1 , wherein the injectable fluid material is effective to reinforce the subchondral bone.
14. The method of claim 1 , wherein the injectable fluid material includes a calcium phosphate.
15. The method of claim 1 , wherein the subchondral bone is in a proximal tibia.
16. The method of claim 1 , wherein the subchondral bone is in a distal femur.